Nasdaq

Stealth BioTherapeutics Presents Positive SBT-272 Preclinical Data at International Parkinson and Movement Disorder Society Virtual Congress 2021

BOSTON, Sept. 23, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel ...
Stockhouse

Stealth BioTherapeutics Presents Positive SBT-272 Preclinical Data at 2021 Annual Northeast Amyotrophic Lateral Sclerosis (NEALS) Meeting

BOSTON, Oct. 7, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies ...
Nasdaq

Stealth BioTherapeutics: Preclinical Data Shows Neuroprotective Effect Of SBT-272

(RTTNews) - Stealth BioTherapeutics Corp. (MITO) presented promising data from a study evaluating the effects of SBT-272 in a murine model of Parkinson's disease. The data showed that SBT-272 has a ...
Cyclingnews.com

SBT GRVL 2021 races

SBT GRVL: Melisa Rollins and Brennan Wertz wrangle wind and late attacks for top honours on new course at Steamboat Springs gravel race North America First-time live broadcast for Leadville 100 MTB ...